PBAX Stock Price, Chart, Stats & News

Phoenix Biotech Acquisition Corp.
Save
36.47M
Market cap
–
Current P/E
–
Forward P/E
PBAX chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -0.07% |
ROA | -1432.29% |
ROE | 2667.41% |
D/E | -0.20x |
Interest coverage ratio | -1387.55x |
PBAX valuation
P/E | – |
P/S | – |
P/B | -1.63x |
P/CF | -0.44x |
P/FCF | -2.18x |
P/OCF | -0.44x |
PEG | 0.01x |
EV multiple | -1.69x |
About
Phoenix Biotech Acquisition Corp. currently lacks substantial business operations. The company's primary objective is to complete a strategic business combination, such as a merger, asset acquisition, share exchange, or other form of reorganization, with one or more suitable enterprises. Its focus is on identifying and integrating with a firm engaged in the healthcare or healthcare-related industries within the United States or Europe.
Similar securities
Based on sector and market capitalization
Report issue











